相关实验视频

Updated: Jul 17, 2025

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

10.1K

在慢性疹中Omalizumab药物存活率:一项回顾性多中心法兰西研究

Julie Litovsky1, Florence Hacard2, Florence Tétart3

  • 1Département de Dermatologie, C.H.U de Montpellier, Montpellier, France.

The journal of allergy and clinical immunology. In practice
|August 31, 2023
PubMed
概括

在法国慢性疹病 (CU) 患者中,奥马利祖马布 (OMA) 显示药物存活时间延长,治疗中断通常是由于疾病控制. 诸如疹类型和自身免疫背景等因素会影响治疗持续时间.

关键词:
慢性尿道病 慢性尿道病药物生存时间 药物生存时间这就是Omalizumab.现实生活中的研究研究.

更多相关视频

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens09:57

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens

Published on: February 14, 2011

12.0K
Basophil Activation Test for Allergy Diagnosis07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

8.3K

相关概念视频

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
342